The ENCHANTMENT HIV Study
NCT04153136
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
HIV/AIDS
Heart Failure With Preserved Ejection Fraction
Interventions
DRUG:
Sacubitril-Valsartan 49-51Mg Oral Tablet
DRUG:
Placebo oral tablet
Sponsor
Massachusetts General Hospital